Herbal brew takes on fatty liver: new trial launches

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18-50 years, both genders eligible; 2. Meets the diagnostic criteria for NAFLD; 3. Meets the diagnostic criteria for Traditional Chinese Medicine Spleen Deficiency and Damp-Heat Syndrome; 4. Has significant risk factors: CAP≥238dB/m, Body Mass Index (BMI) ≥23 kg/m²; 5. Has not received any anti-NAFLD medication treatment in the past month; 6. Normal major organ function, including heart, kidney, and liver functions, specifically: no significant abnormalities on electrocardiogram; normal serum creatinine and urea nitrogen; normal serum bilirubin and albumin levels; 7. Has sufficient cognitive and understanding abilities to comprehend the study content and its potential risks and benefits; 8. Voluntarily participates in the study and signs an informed consent form. Exclusion Criteria: 1. Has liver steatosis due to other definitive causes, such as alcoholic liver disease, drug-induced liver injury, viral hepatitis infections (e.g., hepatitis B, hepatitis C, etc.); 2. Has other serious liver diseases, such as autoimmune liver diseases, primary biliary cholangitis, Wilson's disease, etc.; 3. Has severe dysfunction of major organs such as the heart, kidneys, lungs, etc., such as severe heart failure (NYHA functional classification III or above), renal failure (glomerular filtration rate eGFR \< 30 mL/min/1.73m²), acute exacerbation of chronic obstructive pulmonary disease, etc.; 4. Has other serious systemic diseases, such as malignant tumors, active systemic lupus erythematosus, etc.; 5. Known allergy or intolerance to any component of the study medication; 6. Has participated in another clinical trial within the last three months; 7. Pregnant women, lactating women, or women of childbearing age who refuse to use effective contraception during the trial; 8. Has severe mental illness or behavioral disorders that may affect adherence to the study protocol; 9. Other conditions that the researcher considers unsuitable for participation in this study.